×
About 111,988 results

ALLMedicine™ Atherosclerosis Center

Research & Reviews  55,029 results

Systematic review and meta-analysis of endovascular versus open repair for common femor...
https://doi.org/10.1016/j.jvs.2020.10.026
Journal of Vascular Surgery; Boufi M, Ejargue M et. al.

Oct 25th, 2020 - encouraging recent reports on endovascular treatment of common femoral artery (CFA) atherosclerotic disease renders the question regarding the place of this technique ever-more pertinent and indeed legitimizes randomized trials. This comprehensive...

Dementia in late-onset epilepsy: The atherosclerosis risk in communities study.
https://doi.org/10.1212/WNL.0000000000011080
Neurology Johnson EL, Krauss GL et. al.

Oct 24th, 2020 - To determine the risk of dementia after the development of late-onset epilepsy. We used data from the Atherosclerosis Risk in Communities (ARIC) cohort study, which started in 1987-1989 with 15,792 mostly black and white men and women from 4 U.S. ...

Lipid temporal trends in Normal weight youth.
https://doi.org/10.1016/j.ahj.2020.10.050
American Heart Journal; Zachariah JP, Shittu T et. al.

Oct 23rd, 2020 - Atherosclerosis begins in youth, partly driven by excess weight(EW) and abnormal lipids. Despite pediatric obesity worsening, lipids improved.Given the relation between EW and abnormal lipids, changes in normal weight (NW) youth may be relevant. W...

Zafirlukast prevented ox-LDL-induced formation of foam cells.
https://doi.org/10.1016/j.taap.2020.115295
Toxicology and Applied Pharmacology; Song Q, Hu Z et. al.

Oct 23rd, 2020 - Atherosclerosis (AS), a common arterial disease, is one of the main pathological roots of cardiovascular disease. The formation and accumulation of foam cells is an important event in early AS. An imbalance between cholesterol uptake and efflux is...

Colchicine for the Treatment of Coronary Artery Disease.
https://doi.org/10.1016/j.tcm.2020.10.007
Trends in Cardiovascular Medicine; Aimo A, Pascual-Figal DA et. al.

Oct 23rd, 2020 - Inflammation plays an important role in atherosclerosis. Acute coronary syndromes (ACS), and particularly myocardial infarction (MI), are associated with a systemic inflammatory response that may accelerate coronary atherosclerotic processes, lead...

see more →

Guidelines  149 results

Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Cha...
https://doi.org/10.1016/j.echo.2020.04.021
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography; Johri AM, Nambi V et. al.

Jun 30th, 2020 - Atherosclerotic plaque detection by carotid ultrasound provides cardiovascular disease risk stratification. The advantages and disadvantages of two-dimensional (2D) and three-dimensional (3D) ultrasound methods for carotid arterial plaque quantifi...

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
New England Journal of Medicine; Tardif JC et al

Nov 16th, 2019 - Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.

Subclinical Cardiovascular Disease in HIV Controller & Long‐term Nonprogressor Populations
https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12820
HIV Medicine; Brusca RM,et al

Nov 13th, 2019 - Elite controllers (ECs), viraemic controllers (VCs), and long‐term nonprogressors (LTNPs) control HIV viral replication or maintain CD4 T‐cell counts without antiretroviral therapy, but may have increased cardiovascular disease (CVD) risk compared...

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardio...
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz455/5556353
European Heart Journal; Mach,F.,et al

Aug 29th, 2019 - The previous ESC/EAS lipid Guidelines were published in August 2016.1 The emergence of a substantial body of evidence over the last few years has required new, up-to-date Guidelines. New evidence has confirmed that the key initiating event in ath...

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607207/
Open Access Rheumatology; Peluso R

Jun 27th, 2019 - Psoriatic arthritis (PsA) is a chronic immune-mediated disease. It is associated with an increase in cardiovascular risk factors (obesity, hypertension, diabetes, and dyslipidemia), giving a higher risk of major adverse cardiovascular events. Pati...

see more →

Drugs  111 results see all →

Clinicaltrials.gov  55,669 results

Systematic review and meta-analysis of endovascular versus open repair for common femor...
https://doi.org/10.1016/j.jvs.2020.10.026
Journal of Vascular Surgery; Boufi M, Ejargue M et. al.

Oct 25th, 2020 - encouraging recent reports on endovascular treatment of common femoral artery (CFA) atherosclerotic disease renders the question regarding the place of this technique ever-more pertinent and indeed legitimizes randomized trials. This comprehensive...

Dementia in late-onset epilepsy: The atherosclerosis risk in communities study.
https://doi.org/10.1212/WNL.0000000000011080
Neurology Johnson EL, Krauss GL et. al.

Oct 24th, 2020 - To determine the risk of dementia after the development of late-onset epilepsy. We used data from the Atherosclerosis Risk in Communities (ARIC) cohort study, which started in 1987-1989 with 15,792 mostly black and white men and women from 4 U.S. ...

Lipid temporal trends in Normal weight youth.
https://doi.org/10.1016/j.ahj.2020.10.050
American Heart Journal; Zachariah JP, Shittu T et. al.

Oct 23rd, 2020 - Atherosclerosis begins in youth, partly driven by excess weight(EW) and abnormal lipids. Despite pediatric obesity worsening, lipids improved.Given the relation between EW and abnormal lipids, changes in normal weight (NW) youth may be relevant. W...

Zafirlukast prevented ox-LDL-induced formation of foam cells.
https://doi.org/10.1016/j.taap.2020.115295
Toxicology and Applied Pharmacology; Song Q, Hu Z et. al.

Oct 23rd, 2020 - Atherosclerosis (AS), a common arterial disease, is one of the main pathological roots of cardiovascular disease. The formation and accumulation of foam cells is an important event in early AS. An imbalance between cholesterol uptake and efflux is...

Colchicine for the Treatment of Coronary Artery Disease.
https://doi.org/10.1016/j.tcm.2020.10.007
Trends in Cardiovascular Medicine; Aimo A, Pascual-Figal DA et. al.

Oct 23rd, 2020 - Inflammation plays an important role in atherosclerosis. Acute coronary syndromes (ACS), and particularly myocardial infarction (MI), are associated with a systemic inflammatory response that may accelerate coronary atherosclerotic processes, lead...

see more →

News  951 results

Childhood CV health tied to reduced risk later in life
https://www.mdedge.com/cardiology/article/219104/cad-atherosclerosis/childhood-cv-health-tied-reduced-risk-later-life?channel=39313
Jim Kling

Mar 17th, 2020 - Two observational studies link better cardiovascular health (CVH) in childhood and midlife to reduced CV mortality and subclinical atherosclerosis in later life. Though many studies have examined CVH and CV mortality in later life, the two studies.

Beginning estrogen soon after menopause slows atherosclerosis progression
https://www.mdedge.com/familymedicine/article/218485/lipid-disorders/beginning-estrogen-soon-after-menopause-slows?channel=39313
MDedge Cardiology; Doug Brunk

Mar 5th, 2020 - PHOENIX – Oral estrogen therapy taken within 6 years after the onset of menopause significantly reduced progression of lipid deposition in the carotid arterial wall, compared with placebo. However, starting oral estrogen 10 years after menopause d.

Treating LDL to below 70 reduces recurrent stroke
https://www.mdedge.com/cardiology/article/212864/stroke/treating-ldl-below-70-reduces-recurrent-stroke/page/0/2?channel=39313

Nov 21st, 2019 - However, TST, he said, didn’t provide clear answers on what specific subgroups of patients with a stroke history would benefit from aggressive lipid lowering. “What is stroke without atherosclerotic disease?” he said.

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home
New England Journal of Medicine; Tardif JC et al

Nov 16th, 2019 - Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.

Subclinical Cardiovascular Disease in HIV Controller & Long‐term Nonprogressor Populations
https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.12820
HIV Medicine; Brusca RM,et al

Nov 13th, 2019 - Elite controllers (ECs), viraemic controllers (VCs), and long‐term nonprogressors (LTNPs) control HIV viral replication or maintain CD4 T‐cell counts without antiretroviral therapy, but may have increased cardiovascular disease (CVD) risk compared...

see more →

Patient Education  79 results see all →